IndraLab

Statements

TP53 binds KRAS, BRAF, and GNAS. 1 / 1

| 1

sparser

"In QUASAR 2 (511 tumours), TP53, KRAS, BRAF , and GNAS mutations were independently associated with shorter relapse-free survival (p<0·035 in all cases), and total somatic mutation burden with longer survival (hazard ratio [HR] 0·81 [95% CI 0·68–0·96]; p=0·014)."

30042065

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

TP53 binds KRAS, BRAF, and GNAS. 1 / 1

INDRA sources:

Databases

Reading